key: cord-0859805-e4m02tza
authors: Liu, Dong; Zhang, Qianlong; Bai, Pinqing; Zhao, Jian
title: Assessing causal relationships between COVID-19 and non-alcoholic fatty liver disease
date: 2021-11-20
journal: J Hepatol
DOI: 10.1016/j.jhep.2021.11.014
sha: 650587f624a6355f65d23e24c1df0c2911ce3448
doc_id: 859805
cord_uid: e4m02tza

nan

We read with great interest two manuscripts by Ji infection. 1 However, more recently, Valenti et al. found that metabolic-associated fatty liver disease (MAFLD) may not associate with the susceptibility and severity of COVID-19. 2 Thus, causal relationships between COVID-19 and NAFLD still remain unclear. In this work, we conducted a bidirectional two-sample Mendelian randomization (MR) analysis to examine causal relationships between the COVID-19 susceptibility/severity (including COVID-19 infection, COVID-19 hospitalization, and severe COVID-19 symptoms) and NAFLD.

MR is a causal inference approach by using genetic variants as instrumental variables (IVs) to draw causal inferences between risk factors and health outcomes in observational study settings. It could overcome problems of confounding and reverse causality and becomes widespread for assessing causal relationships. 3 For COVID-19, we used data from the latest and largest genome-wide association All the genetic IVs selected in our study were genome-wide significant (p < 5×10 -8 ) with minor allele frequency greater than 1%. After linkage disequilibrium (LD) clumping (clumping with window = 10,000 kb, R 2 = 0.001 in PLINK 1.9), there were 7 single nucleotide polymorphisms (SNPs) remained for COVID-19 infection, 10

SNPs for hospitalized COVID-19, 8 SNPs for severe COVID-19, and 4 SNPs for NAFLD, respectively ( Fig. 1 panel A) .

In the main MR analysis, we performed separate two-sample MR analyses with three Table S1 -S2 (Supplementary data).

There was no evidence derived from this work to support causal relationships between COVID-19 susceptibility/severity and NAFLD, which are consistent with results from previous genetic studies. 2, 6 On the contrary, Innes et al. found that the rs738409 C>G variant in patatin-like phospholipase domain-containing protein 3 (PNPLA3), which is well studied in the genetic regulation of NAFLD and liver injury, played a protective role in COVID-19 severity. 7 Previous observational studies revealed that COVID-19 infected patients had an increased risk of liver injury 8, 9 , however unmeasured/unmeasurable confounding cannot be ruled out in the conventional multivariable regression analysis. In fact, our findings derived from the MR analysis could minimize confounding bias or reverse causation. 3 It is worthy of note that collider bias, which could distort the relationship between exposures and outcomes, existed in many observational studies and cannot be completely overcome by MR. 10 To investigate the potential impact of collider bias on the MR estimation, we replicated the bidirectional two-sample MR analysis using data from a previously published GWAS by Namjou et al., where genetic associations might be biased due to adjusting for a collider variable (e.g., body mass index (BMI)). Details on methods, results, and directed acyclic graph (DAG) are included in Supplementary data. Future larger randomly sampled cohort studies on COVID-19 and NAFLD and rigorous statistical analysis might be helpful to minimize the impact of collider bias.

In conclusion, we found little evidence to support a causal relationship between COVID-19 susceptibility/severity and NAFLD. 

Non-alcoholic fatty liver diseases in patients with COVID-19: A retrospective study

Lack of genetic evidence that fatty liver disease predisposes to COVID-19

Mendelian randomization: genetic anchors for causal inference in epidemiological studies

The COVID-19 Host Genetics Initiative, a global initiative to elucidate the role of host genetic factors in susceptibility and severity of the SARS-CoV-2 virus pandemic

The MR-Base platform supports systematic causal inference across the human phenome

Genetic insight into COVID-19-related liver injury

The rs738409 G Allele in PNPLA3 Is Associated With a Reduced Risk of COVID-19 Mortality and Hospitalization

Liver injury in COVID-19: management and challenges

COVID-19 and liver disease: mechanistic and clinical perspectives

Collider bias undermines our understanding of COVID-19 disease risk and severity

The authors received no financial support to produce this work.

The authors declare no conflicts of interest that relate to this work.Please refer to the accompanying ICMJE disclosure forms for further details.

All authors drafted and reviewed this manuscript.